Fingerprint
Dive into the research topics of 'Final analysis of the efficacy and safety of omacetaxine mepesuccinate in patients with chronic- or accelerated-phase chronic myeloid leukemia: Results with 24 months of follow-up'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically